165.80EUR+0.73%Mkt Cap: 13.68B EURP/E: 31.20Last update: 2026-05-14
Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide. Its oncology products include Somatuline for the treatment of neuroendocr…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
2.79BEURP/E 24.1
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)31.20
P/E (Forward)12.33
PEG1.15
P/B3.16
P/S3.48
EV/EBITDA9.82
EV/Revenue3.35
EPS (TTM)5.31
EPS (Forward)13.47
Cash Flow & Leverage
FCF Yield4.77%
FCF Margin16.59%
Operating CF1.14B EUR
CapEx (TTM)328.70M EUR
Net Debt/EBITDA-0.41
Net Debt-556.10M EUR
Technical
SMA 50161.29 (+2.8%)
SMA 200134.47 (+23.3%)
Beta0.33
S&P 52W Chg24.23%
Avg Vol (30d)113.65K
Avg Vol (10d)99.82K
Technical Indicators
RSI (14)52.9
MACD1.6070
MACD Signal2.0599
MACD Hist.-0.4530
BB Upper171.34 EUR
BB Middle164.99 EUR
BB Lower158.64 EUR
BB Width7.69%
ATR (14)4.110 EUR
Vol Ratio (20d)0.66x
52W Range
100.0090% of range173.50
52W High173.50 EUR
52W Low100.00 EUR
Profitability
Gross Margin80.89%
EBITDA Margin34.11%
Profit Margin11.29%
Oper. Margin26.10%
ROE10.23%
ROA6.39%
Revenue Growth9.30%
Earnings Growth-3.90%
Balance Sheet
Debt/Equity0.20
Current Ratio1.96
Quick Ratio1.69
Book Value/Sh52.47 EUR
Cash/Share18.47 EUR
Dividends
Fwd Div Rate1.600 EUR
Trail. Div Rate1.400 EUR
Div. Yield0.96%
5Y Avg Yield1.12%
Payout Ratio26.32%
Ex-Div DateJun 3, 2026
Pay Date—
Ownership
Shares Out.82.41M
Float29.86M
Insiders57.23%
Institutions17.20%
Analyst Consensus
Rating2.4 (Buy)
Target (Mean)155.75 EUR
Target Range117.00 EUR – 183.00 EUR
# Analysts16
Company
Market Cap13.68B EUR
Enterprise Value13.16B EUR
Revenue (TTM)3.93B EUR
Gross Profit3.18B EUR
Net Income (TTM)443.50M EUR
Revenue/Share47.54 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees5.5K
Last Price165.80 EUR
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—